Compounded semaglutide and tirzepatide from a USA-based, FDA-registered 503B pharmacy. Physician supervision included from day one.
LegitScript certification is the telehealth industry's gold standard for pharmacy safety and legal compliance. Most GLP-1 providers never apply. We did — and we passed.
Our compounds are produced at a 503B FDA-registered outsourcing facility, not a standard compounding pharmacy. That difference is everything.
Answer a short health questionnaire. No video call required. Takes under 5 minutes from any device.
A US-licensed physician reviews your intake within 24 hours and writes your personalized prescription.
Your medication ships from our 503B partner in discreet, temperature-controlled packaging. Arrives in 5–7 days.
Dose adjustments, check-ins, and physician messaging — all included in your monthly membership.
Semaglutide or tirzepatide prescribed to your profile. Produced at an FDA-registered 503B outsourcing facility in the USA.
US-licensed physicians review your intake, prescribe your protocol, and adjust your dose as you progress. Always included.
Independently verified by LegitScript — the certification standard used by Google and major platforms to validate safe telehealth providers.
Secure patient login, messaging, lab review, and prescription management — all in one place, available 24/7.
Temperature-controlled, discreetly packaged. Ships directly to your door in 5–7 business days from our USA pharmacy partner.
No lock-in. No cancellation fees. Pause or cancel from your member portal whenever you need — no questions asked.
"I didn't expect the level of physician access. Three dose adjustments in the first month alone. That kind of attention is unheard of anywhere else."
Apply for membership today. Physician review within 24 hours. First shipment in 5–7 days. GLP-1 starting at $169/month.
Start now →GLP-1 receptor agonists including compounded semaglutide and tirzepatide may have serious side effects, including possible thyroid tumors. Do not use if you or your family have a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). These are compounded medications and are not FDA-approved for any specific indication. All medications are prescribed at the independent clinical judgment of US-licensed physicians. Individual results vary. This page is for informational purposes only and does not constitute medical advice.